These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1661377)

  • 1. Development of opioid peptide analogs as pharmacologic tools and as potential drugs: current status and future directions.
    Schiller PW
    NIDA Res Monogr; 1991; 112():180-97. PubMed ID: 1661377
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Chung NN; Lemieux C; Marsden BJ; Wilkes BC
    NIDA Res Monogr; 1993; 134():238-52. PubMed ID: 8289881
    [No Abstract]   [Full Text] [Related]  

  • 3. Conformational analysis of opioid receptor-selective peptides using nuclear magnetic resonance and theoretical calculations.
    Hruby VJ; Prakash O; Kazmierski W; Gehrig C; Matsunaga TO
    NIDA Res Monogr; 1991; 112():198-217. PubMed ID: 1661378
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid receptors: development of selective peptidomimetics with agonist or antagonist activity.
    Ronsisvalle G; Pappalardo MS; Spampinato S; Mele A
    Farmaco; 1991 Jan; 46(1 Suppl):171-5. PubMed ID: 1649610
    [No Abstract]   [Full Text] [Related]  

  • 5. Design of conformationally constrained cyclic peptides with high delta and mu opioid receptor specificities.
    Hruby VJ
    NIDA Res Monogr; 1986; 69():128-47. PubMed ID: 3020412
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic peptide combinatorial libraries may be used to determine peptide ligands for opioid receptors.
    Houghten RA; Dooley CT
    NIDA Res Monogr; 1993; 134():66-74. PubMed ID: 8289887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrophysiological aspects of the properties of potentially addictive drugs].
    Seutin V; Dresse A
    Acta Psychiatr Belg; 1990; 90(1):37-45. PubMed ID: 1670389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic structure-activity studies of peptide and nonpeptide flexible opioids: an interdisciplinary approach.
    Loew GH; Toll L; Uyeno E; Cheng A; Judd A; Lawson J; Keys C; Amsterdam P; Polgar W
    NIDA Res Monogr; 1986; 69():231-65. PubMed ID: 3020415
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo characterization of opioid activities of endomorphins analogs with novel constrained C-terminus: evidence for the important role of proper spatial disposition of the third aromatic ring.
    Yu Y; Shao X; Wang CL; Liu HM; Cui Y; Fan YZ; Liu J; Wang R
    Peptides; 2007 Apr; 28(4):859-70. PubMed ID: 17276550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of opioid receptors.
    Raynor K; Kong H; Law S; Heerding J; Tallent M; Livingston F; Hines J; Reisine T
    NIDA Res Monogr; 1996; 161():83-103. PubMed ID: 8784846
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical tools in opioid research.
    Portoghese PS
    NIDA Res Monogr; 1992; 119():27-33. PubMed ID: 1331796
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of opioids. Part 1. Basic aspects.
    Mather LE
    Med J Aust; 1986 Apr; 144(8):424-7. PubMed ID: 3007955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Structural-functional relations of short analogs of enkephalin].
    Rozental' GF; Chipens GI
    Bioorg Khim; 1986 Jul; 12(7):869-97. PubMed ID: 3021174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta-casomorphin derivatives on gastrointestinal transit in mice.
    Becker A; Hempel G; Grecksch G; Matthies H
    Biomed Biochim Acta; 1990; 49(11):1203-7. PubMed ID: 1965564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphinics receptors and endorphines (author's transl)].
    de Luna Infante MJ; Pérez Carvajal A
    Rev Esp Anestesiol Reanim; 1981 Sep; 28(5):293-300. PubMed ID: 6276945
    [No Abstract]   [Full Text] [Related]  

  • 16. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynorphin---A potent opioid peptide (author's transl)].
    Tachibana S
    Tanpakushitsu Kakusan Koso; 1981 Feb; 26(2):115-24. PubMed ID: 6115453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Opiate receptors of the brain].
    Mogilevskiĭ AIa; Alekseeva NS; Derzhiruk LP
    Fiziol Zh (1978); 1987; 33(2):98-108. PubMed ID: 3034682
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endorphin component of endogenic opioid system: location, reception, function].
    Maslov LN; Lishmanov IuB; Terashvili M; Malkova NV
    Patol Fiziol Eksp Ter; 2004; (3):15-23. PubMed ID: 15446415
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro evaluation of a casomorphin related pentapeptide, a competitive mu opioid receptor antagonist.
    Davis P; Tourwe D; Delaet N; Kramer TH; Burks TF
    Proc West Pharmacol Soc; 1991; 34():429-32. PubMed ID: 1664962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.